Of note, hsa-miR-605-3p targets COL4A1, PNKD, TGFBR2, and YAP1, which have been identified as susceptible genes in migraine patients (Gormley et al., 2016; Khan et al., 2021). This evidence concerns the gene TGFBR2 and migraine disorder.